These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 33459490)
1. An innovative standard for LC-MS-based HCP profiling and accurate quantity assessment: Application to batch consistency in viral vaccine samples. Trauchessec M; Hesse AM; Kraut A; Berard Y; Herment L; Fortin T; Bruley C; Ferro M; Manin C Proteomics; 2021 Mar; 21(5):e2000152. PubMed ID: 33459490 [TBL] [Abstract][Full Text] [Related]
2. Toward unbiased identification and comparative quantification of host cell protein impurities by automated iterative LC-MS/MS (HCP-AIMS) for therapeutic protein development. Huang Y; Molden R; Hu M; Qiu H; Li N J Pharm Biomed Anal; 2021 Jun; 200():114069. PubMed ID: 33901758 [TBL] [Abstract][Full Text] [Related]
3. SWATH-MS as a strategy for CHO host cell protein identification and quantification supporting the characterization of mAb purification platforms. Carvalho SB; Profit L; Krishnan S; Gomes RA; Alexandre BM; Clavier S; Hoffman M; Brower K; Gomes-Alves P J Biotechnol; 2024 Mar; 384():1-11. PubMed ID: 38340900 [TBL] [Abstract][Full Text] [Related]
4. Identification and characterization of co-purifying CHO host cell proteins in monoclonal antibody purification process. Liu X; Chen Y; Zhao Y; Liu-Compton V; Chen W; Payne G; Lazar AC J Pharm Biomed Anal; 2019 Sep; 174():500-508. PubMed ID: 31234041 [TBL] [Abstract][Full Text] [Related]
5. ELISA reagent coverage evaluation by affinity purification tandem mass spectrometry. Henry SM; Sutlief E; Salas-Solano O; Valliere-Douglass J MAbs; 2017 Oct; 9(7):1065-1075. PubMed ID: 28708446 [TBL] [Abstract][Full Text] [Related]
6. A Novel Sample Preparation for Shotgun Proteomics Characterization of HCPs in Antibodies. Huang L; Wang N; Mitchell CE; Brownlee T; Maple SR; De Felippis MR Anal Chem; 2017 May; 89(10):5436-5444. PubMed ID: 28414239 [TBL] [Abstract][Full Text] [Related]
7. A novel approach to evaluate ELISA antibody coverage of host cell proteins-combining ELISA-based immunocapture and mass spectrometry. Pilely K; Nielsen SB; Draborg A; Henriksen ML; Hansen SWK; Skriver L; Mørtz E; Lund RR Biotechnol Prog; 2020 Jul; 36(4):e2983. PubMed ID: 32087048 [TBL] [Abstract][Full Text] [Related]
8. Improved host cell protein analysis in monoclonal antibody products through ProteoMiner. Chen IH; Xiao H; Li N Anal Biochem; 2020 Dec; 610():113972. PubMed ID: 32979367 [TBL] [Abstract][Full Text] [Related]
9. Toward the complete characterization of host cell proteins in biotherapeutics via affinity depletions, LC-MS/MS, and multivariate analysis. Madsen JA; Farutin V; Carbeau T; Wudyka S; Yin Y; Smith S; Anderson J; Capila I MAbs; 2015; 7(6):1128-37. PubMed ID: 26291024 [TBL] [Abstract][Full Text] [Related]
10. Identification and Quantification of a Problematic Host Cell Protein to Support Therapeutic Protein Development. E SY; Hu Y; Molden R; Qiu H; Li N J Pharm Sci; 2023 Mar; 112(3):673-679. PubMed ID: 36220394 [TBL] [Abstract][Full Text] [Related]
11. Comparison of platform host cell protein ELISA to process-specific host cell protein ELISA. Gunawan F; Nishihara J; Liu P; Sandoval W; Vanderlaan M; Zhang H; Krawitz D Biotechnol Bioeng; 2018 Feb; 115(2):382-389. PubMed ID: 28986978 [TBL] [Abstract][Full Text] [Related]
12. Improved Host Cell Protein Analysis in Monoclonal Antibody Products through Molecular Weight Cutoff Enrichment. Chen IH; Xiao H; Daly T; Li N Anal Chem; 2020 Mar; 92(5):3751-3757. PubMed ID: 31999105 [TBL] [Abstract][Full Text] [Related]
13. Applying UHPLC-HRAM MS/MS Method to Assess Host Cell Protein Clearance during the Purification Process Development of Therapeutic mAbs. Kiyonami R; Melani R; Chen Y; Leon AI; Du M Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273634 [TBL] [Abstract][Full Text] [Related]
14. Host Cell Protein Profiling by Targeted and Untargeted Analysis of Data Independent Acquisition Mass Spectrometry Data with Parallel Reaction Monitoring Verification. Kreimer S; Gao Y; Ray S; Jin M; Tan Z; Mussa NA; Tao L; Li Z; Ivanov AR; Karger BL Anal Chem; 2017 May; 89(10):5294-5302. PubMed ID: 28402653 [TBL] [Abstract][Full Text] [Related]
15. Identification of a host cell protein impurity in therapeutic protein, P1. Ahluwalia D; Dhillon H; Slaney T; Song H; Boux H; Mehta S; Zhang L; Valdez A; Krishnamurthy G J Pharm Biomed Anal; 2017 Jul; 141():32-38. PubMed ID: 28419935 [TBL] [Abstract][Full Text] [Related]
16. Integrated strategy for deep profiling of host cell proteins in downstream processing of therapeutic monoclonal antibodies: Novel approach to isolate and digest host cell proteins. Zarei M; Jonveaux J; Razvi A; Jahn M Eur J Pharm Biopharm; 2024 Aug; 201():114369. PubMed ID: 38885909 [TBL] [Abstract][Full Text] [Related]
18. A highly sensitive and robust LC-MS platform for host cell protein characterization in biotherapeutics. Ji Q; Sokolowska I; Cao R; Jiang Y; Mo J; Hu P Biologicals; 2023 May; 82():101675. PubMed ID: 37028215 [TBL] [Abstract][Full Text] [Related]
19. Harnessing the power of electrophoresis and chromatography: Offline coupling of reverse phase liquid chromatography-capillary zone electrophoresis-tandem mass spectrometry for analysis of host cell proteins in monoclonal antibody producing CHO cell line. Kumar R; Shah RL; Ahmad S; Rathore AS Electrophoresis; 2021 Mar; 42(6):735-741. PubMed ID: 33348443 [TBL] [Abstract][Full Text] [Related]
20. Sensitive, Rapid, Robust, and Reproducible Workflow for Host Cell Protein Profiling in Biopharmaceutical Process Development. Ma J; Kilby GW J Proteome Res; 2020 Aug; 19(8):3396-3404. PubMed ID: 32449362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]